Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 5.20084 | 77 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 5.38966 | 78 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 5.17111 | 76 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 5.02717 | 75 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 5.19562 | 77 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 5.21202 | 78 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 5.23 | 78 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 5.17514 | 77 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 5.17203 | 76 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 5.12484 | 76 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 5.13889 | 76 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 5.22785 | 77 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 5.18558 | 77 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 5.35368 | 78 |